使用入院信息预测极早产婴儿的死亡和没有重大疾病的存活率:一个多中心队列研究
Xincheng Cao1,2, Shujuan Li1,2, Xinyue Gu2
1Department of Neonatology, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China.
Translational pediatrics
|June 16, 2025
概括
使用NICU入院数据开发了极度早产婴儿 (EPI) 的准确预测模型. 这些模型可以预测死亡率和没有重大发病率的生存率,有助于临床决策.
科学领域:
- 新生儿科学 新生儿科学
- 医疗信息学 医疗信息学
- 预测分析是一种预测分析.
背景情况:
- 准确预测极早产婴儿 (EPI) 的结果对于临床和家长的决策至关重要.
- 早期预测有助于管理怀孕24至28周之间出生的脆弱婴儿的护理.
研究的目的:
- 开发和验证EPI中死亡率和没有重大发病率的生存预测模型.
- 利用新生儿重症监护室 (NICU) 入院预测的随时可用的信息.
主要方法:
- 在中国利用了两大当代EPI队伍 (开发和验证).
- 开发了后勤回归模型来预测死亡率和没有重大疾病的生存率.
- 确定了预测因素,包括妊娠年龄,出生体重,性别,产前类固醇,5分钟的阿巴格得分和入院时的侵入性通风.
主要成果:
- 发育队列中的死亡率为17.7%,验证队列中的死亡率为9.2%.
- 没有重大发病率的生存率为52.5% (发育) 和59.1% (验证).
- 死亡模型的AUC为0.77 (发展) 和0.76 (验证);生存模型的AUC为0.72 (发展) 和0.70 (验证).
结论:
- 成功开发和验证了两个不同的模型来预测EPI结果.
- 模型使用常见的NICU入院预测器,提供可接受的性能.
- 这些工具可以帮助管理极度早产的婴儿.
相关概念视频
Assumptions of Survival Analysis
200
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
200
Actuarial Approach
140
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
140
Kaplan-Meier Approach
281
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
281
Comparing the Survival Analysis of Two or More Groups
303
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
303
Cancer Survival Analysis
458
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
458
Introduction To Survival Analysis
409
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
409


